| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 01/02/2002 | EP1165551A1 C10 carbamoyloxy substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165550A1 C10 carbonate substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165549A1 C7 carbamoyloxy substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165528A1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
| 01/02/2002 | EP1165505A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 01/02/2002 | EP1165096A2 Use of cytidine derivatives for the treatment of leukaemia |
| 01/02/2002 | EP1165069A1 Antitumour synergistic composition |
| 01/02/2002 | EP1165058A2 Use of azalide antibiotics for the topical treatment or prevention of ocular infections |
| 01/02/2002 | EP1165026A1 Oxidation dyeing method using n-acetylcysteine as a reducing agent and laccase as an oxidating agent |
| 01/02/2002 | EP0958307B1 O-sulfated bacterial polysaccharides |
| 01/02/2002 | CN1329620A Analogues of GLP-1 |
| 01/02/2002 | CN1329617A Hygromycin A derivatives as antibacterial agents |
| 01/02/2002 | CN1329607A Substituted benzopyran analogs for treatment of inflammation |
| 01/02/2002 | CN1329605A Benzofuran derivatives their preparation and use |
| 01/02/2002 | CN1329486A Method for producing agglomerates comprising core-shell structure |
| 01/02/2002 | CN1328824A Compound for curing female sexual disorder |
| 01/01/2002 | US6335345 Spiro compounds |
| 01/01/2002 | US6335033 Melt-extrusion multiparticulates |
| 12/27/2001 | WO2001097768A2 Method of making enhanced efficacy antiperspirant actives |
| 12/27/2001 | WO2001034189A3 Vaccines for mycoplasma bovis and methods of use |
| 12/27/2001 | US20010056125 Local anesthetic methods and kits |
| 12/27/2001 | US20010056063 Method of treating or preventing type 1 diabetes by oral administration of insulin |
| 12/27/2001 | US20010055626 Apparatus and process for in situ manufacture of essence from living, uncut plants |
| 12/27/2001 | US20010055625 Herbal composition and method of manufacturing such composition for the management of gynecological disorders |
| 12/27/2001 | US20010055597 Oil in water emulsions containing retinoids |
| 12/27/2001 | US20010055568 Oral, nasal and pulmonary dosage formulations of copolymer 1 |
| 12/27/2001 | US20010055567 Uses water-soluble dyes and their biomolecule adducts, each having specific photophysical and pharmaco-chemical properties, as contrast media for fluorescence and transillumination diagnostics |
| 12/27/2001 | CA2412478A1 Method of making enhanced efficacy antiperspirant actives |
| 12/26/2001 | CN1328554A Eletriptan hydrobromide monohydrate |
| 12/26/2001 | CN1328469A Use of parvovirus capsid particles in inhibition of cell proliferation and migration |
| 12/26/2001 | CN1328465A Use of phosphonoformic acid derivatives for treating infections |
| 12/26/2001 | CN1328457A Use of N-substituted-1,5-dideoxy -1,5-imino-D-glucitol compounds for treating hepatitis virus |
| 12/26/2001 | CN1328445A Pressurised metered dose inhalers |
| 12/26/2001 | CN1327793A Pyrrolo-triazine and pyrimidine compounds |
| 12/20/2001 | WO2001096338A1 Non-nucleoside reverse transcriptase inhibitors |
| 12/20/2001 | WO2001096308A1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| 12/20/2001 | WO2001095870A2 Compositions with low irritancy |
| 12/20/2001 | WO2001007047A3 Control of crustacean infestation of aquatic animals |
| 12/20/2001 | WO2000066602A9 3-deoxy-desmycosin derivatives and process for their preparation |
| 12/20/2001 | US20010053800 Long chain monounsaturated alcohol mixtures |
| 12/19/2001 | EP1164132A2 Crystalline magnesium omeprazole |
| 12/19/2001 | EP1163234A1 Improved aqueous solubility pharmaceutical formulations |
| 12/19/2001 | EP1163000A2 Vaccine against antigens from bacteriae |
| 12/19/2001 | EP1162999A2 Vaccine against Streptococcus pneumoniae |
| 12/19/2001 | EP1162998A2 Vaccine against streptococcus pneumoniae capsular polysaccharides |
| 12/19/2001 | EP1162966A1 Weight loss after pregnancy |
| 12/19/2001 | EP1162965A1 Method of controlling weight gain associated with therapeutic drugs |
| 12/19/2001 | EP1162959A2 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
| 12/19/2001 | EP0966249A4 Hair coloring compositions |
| 12/19/2001 | EP0914098A4 Multi-layered osmotic device |
| 12/19/2001 | CN1076356C Protein having TPO activity |
| 12/19/2001 | CN1076205C Particles for NMR imaging and method of manufacture |
| 12/18/2001 | US6331571 Methods of treating and preventing attention deficit disorders |
| 12/18/2001 | US6331568 Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid |
| 12/18/2001 | US6331565 Inhibit virus dna replication and antigen expression |
| 12/18/2001 | CA2074215C Improved oral dosing formulations of dideoxy purine nucleosides |
| 12/13/2001 | WO2001094368A1 2-aminocarbonyl-9h-purine derivatives |
| 12/13/2001 | WO2001094341A1 Quinazoline derivatives for the treatment of tumours |
| 12/13/2001 | WO2001041701A3 The combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
| 12/13/2001 | US20010051640 C7 carbamoyloxy substituted taxanes |
| 12/13/2001 | US20010049850 Mixture containing 2-amino-3-hydroxypyridine coupler and oxidoreductase enzyme |
| 12/13/2001 | DE10027946A1 Dental ceramic used in dentistry as filling material and tooth replacement is anisotropic and contains a large amount of hydroxylapatite |
| 12/12/2001 | EP1161247A1 Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic |
| 12/12/2001 | EP1113824A4 Reactive nanoparticles as destructive adsorbents for biological and chemical contamination |
| 12/12/2001 | EP1032379B1 Composition with azelaic acid |
| 12/12/2001 | EP0861248B1 Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands |
| 12/12/2001 | EP0755243B1 Detergent composition |
| 12/12/2001 | EP0671903B1 Topical and transdermal delivery system utilizing submicron oil spheres |
| 12/12/2001 | CN1326341A Dry powder for inhalation |
| 12/11/2001 | US6329397 Hydroxy pipecolate hydroxamic acid derivatives |
| 12/11/2001 | US6329000 Extract of pine needle and the use thereof |
| 12/11/2001 | CA2205033C Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors |
| 12/11/2001 | CA2136429C Combined vaccines comprising hepatitis b surface antigen and other antigens |
| 12/06/2001 | WO2001092282A2 Methods and compositions for treating flaviviruses and pestiviruses |
| 12/06/2001 | WO2001092239A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists |
| 12/06/2001 | WO2001092230A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 12/06/2001 | WO2001091763A2 Extracts from spermatophyte plants with antitumor activity |
| 12/06/2001 | WO2001091756A2 S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders |
| 12/06/2001 | CA2410618A1 S-methyl-dihydro-ziprasidone for treatment of psychiatric disorders |
| 12/06/2001 | CA2409006A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists |
| 12/05/2001 | EP1159966A2 Composition for the treatment of psoriasis |
| 12/05/2001 | EP1159955A1 Carrier particles for use in dry powder inhalers |
| 12/05/2001 | EP1158978A1 Medicament against dysmenorrhoea and premenstrual syndrome |
| 12/05/2001 | EP1026947B1 Composition and method for treating penile erectile dysfunction |
| 12/05/2001 | EP1017360B1 Nonaerosol shave gel compositions |
| 12/05/2001 | EP0994872B9 4-phenylpiperidine compounds |
| 12/05/2001 | EP0971880B1 Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid |
| 12/05/2001 | EP0763114B1 Hepatitis g virus and molecular cloning thereof |
| 12/05/2001 | EP0745075B1 6-substituted mycophenolic and derivatives with immunosuppressive activity |
| 12/05/2001 | EP0445255B2 USE OF HYALURONIC ACID IN COMBINATION WITH ASCORBIC ACID, ANTITUMOUR AGENTS AND/OR NSAIDs FOR TREATING CANCER |
| 12/05/2001 | CN1325304A 5HT1 receptor agonists and metoclopramide for treatment of migraine |
| 12/05/2001 | CN1325297A Cosmetic composition |
| 12/05/2001 | CN1325296A Fluorinated toothpaste composition comprising calcic material abrasive particles compatible with fluorine |
| 12/05/2001 | CN1075722C Fungicidal compositions containing bifonazole |
| 12/04/2001 | US6326375 Containing an urea group |
| 12/04/2001 | US6326027 Solid, oral dosage form, comprising tramadol or its salt in matrix providing at least twelve hour effectiveness |
| 12/04/2001 | CA2085884C Pressurized hydrofluorocarbon aerosol compositions |
| 11/29/2001 | WO2001090311A1 Novel probiotics for pet food applications |
| 11/29/2001 | WO2001089480A1 Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
| 11/29/2001 | WO2001089465A2 Emulsions with naphthalate esters |